Need a specific person's email?
Browse Entero Therapeutics (Nasdaq: ENTO)'s employee directory (about 5 employees) and reveal verified emails free.
Entero Therapeutics (Nasdaq: ENTO)'s most common email format is FLast@azurrx.com (ex. JDoe@azurrx.com), used for 83% of azurrx.com addresses. Entero Therapeutics (Nasdaq: ENTO) uses 4 email patterns.
| Format | Example | Share of azurrx.com |
|---|---|---|
| FLast@azurrx.comMost common | JDoe@azurrx.com | |
| First.Last@azurrx.com | John.Doe@azurrx.com | |
| LastFir@azurrx.com | DoeJoh@azurrx.com | |
| LastFi@azurrx.com | DoeJo@azurrx.com |
Browse Entero Therapeutics (Nasdaq: ENTO)'s employee directory (about 5 employees) and reveal verified emails free.
Pharmaceutical ManufacturingFlorida, United States2-10 Employees
Entero Therapeutics is a late-stage biopharmaceutical company based in Boca Raton, Florida, with clinical operations in Hayward, California. It develops targeted, non-systemic therapies for gastrointestinal diseases, pursuing unmet GI health needs through a portfolio that includes latiglutenase for celiac disease, which is Phase 3 ready, capeserod for gastroparesis, and adrulipase for exocrine pancreatic insufficiency. The company builds its development pipeline around two proprietary technologies, niclosamide and adrulipase, with several clinical programs and forthcoming formulations. In October 2025, Entero Therapeutics acquired GRID AI Corp, signaling a strategic move into AI and data-center applications.
Most common format
FLast@azurrx.com
Example: JDoe@azurrx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.